Eli Lilly has invested in Abridge as the health tech startup expands into clinical trial recruitment and broadens its reach into the life sciences.
Shiv Rao, Abridge CEO (Michael Nagle/Bloomberg via Getty Images)
June 12, 2026 01:38 PM EDT
Eli Lilly invests in startup Abridge for clinical trial recruitment
Eli Lilly has invested in Abridge as the health tech startup expands into clinical trial recruitment and broadens its reach into the life sciences.
The …
Since launching eight years ago with an ambient medical transcription tool, Abridge has set is sights more broadly on building…
Abridge announced new deals with Eli Lilly and Nvidia as it aims to gain an edge in a competitive market.
The $5.3 billion ambient AI startup is expanding from clinical notes into billing, drug trials, and real-time insurance claims.
Worth as much as $1.9 billion, the deal directs Ascidian to help Lilly find potential drugs for genetically driven kidney…
Eli Lilly has partnered with basketball star | Eli Lilly has partnered with basketball star Caitlin Clark’s foundation to open…
Nonprofit Blood Cancer United acquires cancer drug, Lilly and Nvidia invest in Abridge, and more biotech news
Abridge wants to be the operating system for medicine—and NVIDIA and Eli Lilly are helping build it | Fortune
